Assembly Biosciences, Inc (ASMB) is a publicly traded Healthcare sector company. As of August 13, 2026, ASMB trades at $30.49 with a market cap of $536.25M and a P/E ratio of -53.94. ASMB moved +8.46% today. Year to date, ASMB is -11.25%; over the trailing twelve months it is +21.01%. Its 52-week range spans $7.75 to $39.71. Analyst consensus is strong buy with an average price target of $46.00. Rallies surfaces ASMB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for ASMB, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $30.49 |
| Market Cap | $536.25M |
| P/E Ratio | -53.94 |
| EPS | $-0.55 |
| Dividend Yield | 0.00% |
| 52-Week High | $39.71 |
| 52-Week Low | $7.75 |
| Volume | 694.33K |
| Avg Volume | 0 |
| Revenue (TTM) | $72.30M |
| Net Income | $-6.12M |
| Gross Margin | 0.00% |
3 analysts cover ASMB: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $46.00.